We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
High Costs Hurt Cullen/Frost (CFR), Loan Concentration Ails
Read MoreHide Full Article
Cullen/Frost Bankers, Inc. (CFR - Free Report) is affected by mounting costs primarily due to expansion moves. This will likely impede bottom-line growth. Also, deterioration in credit quality and an undiversified loan portfolio are concerning. Nonetheless, a rise in net interest income (NII), solid loan balances and steady capital deployment plans are positives.
Cullen/Frost’s elevating cost base exposes it to operational risks. Non-interest expenses have been rising over the years. This has mainly stemmed from a rise in compensation-related expenditures.
Going forward, costs arelikely to remain elevated on expansion moves in the Texas region. Management expects expenses to rise in mid-teens for 2023. We estimate non-interest expenses to jump 13.7% this year.
The credit quality of Cullen/Frost seems to have worsened over the years. Though allowance for credit losses on loans as a percentage of total loans declined to 1.32% in the first half of 2023, it remains high.Further, the ratio of net charge-offs to total average loans increased in 2022 and reached 0.21% in the first half of 2023.
The worsening economic outlook is expected to adversely impact its credit quality. Our estimate for provision indicates a substantial surge this year.
CFR's loan portfolio comprises majorly of commercial loans (C&I as well as commercial real estate or CRE lending). In fact, its loan mix underpinned nearly 80% of CRE and C&I loans as of Jun 30, 2023.
The current rapidly changing macroeconomic backdrop may put some strain on commercial lending. Moreover, in case of any economic downturn, the asset quality of the loan category might deteriorate. Thus, the lack of loan portfolio diversification is likely to hurt the company’s financials if the economic situation worsens.
Nonetheless, Cullen/Frost’s solid balance sheet position and NII growth offer some support to its financials. Additionally, its efforts to expand branches in the Texas region will further aid balance sheet growth. Also, steady capital deployment activitiesstoke investors’ confidence in the stock.
In the past three months, shares of this Zacks Rank #4 (Sell) company have lost 3.5% against the industry's growth of 7.9%.
The Zacks Consensus Estimate for JPM’s 2023 earnings has been revised 1% upward over the past month. The stock has gained 6.8% over the past three months.
The consensus estimate for LOB’s 2023 earnings has revised 19.7% upward over the last 30 days. The company’s share price has increased 50.4% over the past three months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
High Costs Hurt Cullen/Frost (CFR), Loan Concentration Ails
Cullen/Frost Bankers, Inc. (CFR - Free Report) is affected by mounting costs primarily due to expansion moves. This will likely impede bottom-line growth. Also, deterioration in credit quality and an undiversified loan portfolio are concerning. Nonetheless, a rise in net interest income (NII), solid loan balances and steady capital deployment plans are positives.
Cullen/Frost’s elevating cost base exposes it to operational risks. Non-interest expenses have been rising over the years. This has mainly stemmed from a rise in compensation-related expenditures.
Going forward, costs arelikely to remain elevated on expansion moves in the Texas region. Management expects expenses to rise in mid-teens for 2023. We estimate non-interest expenses to jump 13.7% this year.
The credit quality of Cullen/Frost seems to have worsened over the years. Though allowance for credit losses on loans as a percentage of total loans declined to 1.32% in the first half of 2023, it remains high.Further, the ratio of net charge-offs to total average loans increased in 2022 and reached 0.21% in the first half of 2023.
The worsening economic outlook is expected to adversely impact its credit quality. Our estimate for provision indicates a substantial surge this year.
CFR's loan portfolio comprises majorly of commercial loans (C&I as well as commercial real estate or CRE lending). In fact, its loan mix underpinned nearly 80% of CRE and C&I loans as of Jun 30, 2023.
The current rapidly changing macroeconomic backdrop may put some strain on commercial lending. Moreover, in case of any economic downturn, the asset quality of the loan category might deteriorate. Thus, the lack of loan portfolio diversification is likely to hurt the company’s financials if the economic situation worsens.
Nonetheless, Cullen/Frost’s solid balance sheet position and NII growth offer some support to its financials. Additionally, its efforts to expand branches in the Texas region will further aid balance sheet growth. Also, steady capital deployment activitiesstoke investors’ confidence in the stock.
In the past three months, shares of this Zacks Rank #4 (Sell) company have lost 3.5% against the industry's growth of 7.9%.
Image Source: Zacks Investment Research
Stocks Worth Considering
A couple of better-ranked stocks are JPMorgan Chase & Co. (JPM - Free Report) and Live Oak Bancshares, Inc. (LOB - Free Report) . Each stock currently sports a Zacks Rank #1 (Strong Buy). You cansee the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for JPM’s 2023 earnings has been revised 1% upward over the past month. The stock has gained 6.8% over the past three months.
The consensus estimate for LOB’s 2023 earnings has revised 19.7% upward over the last 30 days. The company’s share price has increased 50.4% over the past three months.